News | July 20, 2008

High-Intensity Focused Ultrasound Treats Prostate at M.D. Anderson

July 17, 2008 - Urologists at the University of Texas M.D. Anderson Cancer Center treated their first two localized prostate cancer patients with Ablatherm-HIFU (high-intensity focused ultrasound), as part of ENLIGHT, an ongoing Phase II/III clinical trial.

The trial, led by EDAP, is designed to evaluate the minimally invasive, robotized treatment in patients with localized prostate cancer. "We see great promise for Ablatherm-HIFU as a minimally invasive treatment that targets localized prostate cancer, which could effectively treat the disease and allow patients to resume their day-to-day activities with minimal or no downtime. ENLIGHT provides an opportunity to rigorously evaluate this potential," said John F. Ward, M.D., F.A.C.S., assistant professor, Department of Urology at M.D. Anderson Cancer Center, and principle investigator of the trial.

Marc Oczachowski, EDAP's CEO, commented, "We are fortunate to have the world renown M.D. Anderson Cancer Center participating in the ENLIGHT trial which has received Investigational Device Exemption by the FDA. The center’s initial treatments with Ablatherm-HIFU mark a significant milestone in our development program, and additional patients have been scheduled to receive our minimally invasive treatment in the coming weeks. Attracting leading American cancer centers is part of our strategy to gain HIFU visibility and potentially accelerate patient enrollment at all participating sites as we advance towards submission for FDA approval in the U.S. We are confident that the validation from our participating sites, in conjunction with ongoing momentum from our marketing and referral program, continues to generate increased patient awareness of HIFU."

For more information: www.ClinicalTrials.gov and www.edap-tms.com

Related Content

Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
New Vascular Ultrasound Registry Looks to Enhance Patient Care
News | Cardiovascular Ultrasound | January 17, 2018
The Society for Vascular Ultrasound (SVU), the Society for Vascular Surgery (SVS) and Medstreaming-M2S announced the...
Sponsored Content | Videos | Ultrasound Imaging | January 11, 2018
Mindray recently featured a new upgrade for its premium Resona 7 ultrasound system at the Radiological Society of North...
New International Report Provides Comprehensive Guide to Imaging in Chagas Heart Disease
News | Cardiovascular Ultrasound | January 03, 2018
Chagas disease (ChD), an infectious parasitic disease transmitted primarily by triatomine insects, has become a...
Bay Labs Completes $5.5 Million Series A Financing for AI-Driven Ultrasound
News | Cardiovascular Ultrasound | December 21, 2017
December 21, 2017 — Bay Labs, a medical technology company applying...
Toshiba Medical Introduces New Entry-Level Aplio i600 Ultrasound Platform
News | Ultrasound Imaging | December 21, 2017
Toshiba Medical, a Canon Group company, showcased the Aplio i600, the newest addition to the premium Aplio i-series...
Videos | RSNA 2017 | December 20, 2017
ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the
GE and NVIDIA Unveil Artificial Intelligence Upgrades to CT, Ultrasound and Analytics Solutions
Technology | Artificial Intelligence | December 14, 2017
At the 2017 Radiological Society of North America (RSNA) Annual Meeting, GE Healthcare and NVIDIA announced a series of...
Hitachi Highlights Arietta 850 Premium Ultrasound System at RSNA 2017
News | Ultrasound Imaging | December 05, 2017
Hitachi Healthcare exhibited their latest premium ultrasound system, the Arietta 850, at the 2017 Radiological Society...
Overlay Init